Oura has agreed to acquire virtual primary-care company Counsel Health for US$625 million in cash, the companies announced November 10. The price is subject to adjustments, and the transaction is expected to close before the end of 2026, subject to customary conditions.
From wearable measurements to access to care
Counsel combines an AI chat service with access to physicians. The companies say the combination will connect Oura’s biometric information with clinical services, allowing members to move from an insight in the app to a conversation and, where appropriate, a physician.
Counsel is also expected to continue serving enterprise partners. Reuters independently reported the agreement and the expected year-end closing. This remains an announced transaction, not a completed acquisition.
The important distinction for users
The business proposition is a shorter path between collecting information and getting help interpreting it. That does not make a wearable measurement equivalent to a diagnosis, nor does an acquisition announcement establish improved clinical outcomes.
For prospective users and employers, the decisive details are service eligibility, access to clinicians, charges and how information moves between the wearable platform and care provider. Those considerations deserve separate scrutiny from the appeal of a more integrated app. The transaction’s next concrete milestone is closing; broader benefits will have to be demonstrated through the delivered service.
Sources
Original announcement · Reuters reporting
Featured image: AI-generated conceptual illustration; not a depiction of an actual product or event.


